About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
This conference will focus on delving deeper into the main scientific, regulatory, ethical and clinical challenges of the development of Advanced Therapy Medicinal Products (ATMPs), from the preclinical phase to the first clinical trials in humans.
Program
14.30h -14.50h Talk: Vall d’Hebron University Campus as leaders in Clinical Research
14:50h – 15:10h Talk: Vision and Experience of the Pharmaceutical Industry in ATMP Development
15:10h - 15:30h Talk: From Bench to Trial: Regulatory Requirements for ATMP Development
15:30h – 16:05h Round Table From Preclinical to First-in-Human: Ethical and Clinical Trial Design Challenges in ATMP Development
16:05 – 16:20h Coffee break
16:20h – 16:40h Talk: Developing Academic CAR-T Therapies: An Academic Development Model
16:40h – 17:15h Round Table: Managing Uncertainty in ATMPs: High-Risk Administration, Uncertain Long-Term Durability, Immunogenicity, and Patient-Specific Biological Barriers
*Online access available: https://gencat.zoom.us/webinar/register/WN_c3QQkblXQYKIb9vSTU_vxA
